Jack Rowland, MD
Obstetrics & Gynecology · Chattanooga, TNNPI 1417970054
Payments from drug & device makers
Across 165 payments — averaging $44.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Mimedx Group, Inc.$1K
- Mayne Pharma Commercial LLC$350
- Astellas Pharma US Inc$350
- Sage Therapeutics, LLC$308
- Sumitomo Pharma America, Inc.$267
- plus $2K from 34 others
What the payments were for
- Consulting fees$1,20016%
- Travel & lodging$6178%
- Food & beverage$3,51048%
- Education$2,00027%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $2,800 |
| Mimedx Group, Inc. | 5 | $1,200 |
| Mayne Pharma Commercial LLC | 11 | $350 |
| Astellas Pharma US Inc | 10 | $350 |
| Sage Therapeutics, LLC | 18 | $308 |
| Sumitomo Pharma America, Inc. | 13 | $267 |
| Myovant Sciences Inc. | 14 | $250 |
| AbbVie(2 entities) | 10 | $194 |
| Boston Scientific | 10 | $192 |
| Channel Medsystems, Inc. | 2 | $155 |
| Aspira Women's Health Inc | 2 | $149 |
| Coopersurgical, Inc. | 6 | $132 |
| Coloplast | 6 | $117 |
| Organon | 6 | $102 |
| Daiichi Sankyo Inc. | 4 | $79 |
| Hologic Sales And Service, LLC | 4 | $58 |
| Medical Device Business Services, Inc. | 1 | $56 |
| Pfizer | 3 | $55 |
| Therapeuticsmd, Inc. | 3 | $46 |
| Agile Therapeutics, Inc. | 2 | $45 |
| Shield Therapeutics Inc | 3 | $44 |
| Exeltis, USA Inc. | 3 | $43 |
| Urovant Sciences Inc | 2 | $35 |
| Minerva Surgical, Inc | 2 | $27 |
| Alydia Health | 1 | $27 |
| Baxter Healthcare | 1 | $27 |
| Johnson & Johnson | 1 | $25 |
| Avanos Medical | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
| Avion Pharmaceuticals | 1 | $16 |
| Scynexis, Inc. | 1 | $16 |
| Gynesonics, Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
| Smith+Nephew | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $12 |
| Lupin Inc. | 1 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,500
- Da Vinci Surgical System$1,237
- Veozah$125
- NEXTSTELLIS$123
- ANNOVERA$116
How this compares
$7,327 in reported general payments places this provider in the 90th percentile of 763 obstetrics & gynecology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 213 | $11,051 |
| Estradiol | 176 | $6,625 |
| MyrbetriqMirabegron | 14 | $6,171 |
| Estradiol (Twice Weekly)Estradiol | 52 | $4,443 |
| DottiEstradiol | 16 | $1,685 |
| Estradiol Valerate | 15 | $1,441 |
| ValacyclovirValacyclovir Hcl | 32 | $1,040 |
| Oxybutynin Chloride ErOxybutynin Chloride | 28 | $898 |
| Liothyronine Sodium | 17 | $514 |
| Medroxyprogesterone Acetate | 22 | $501 |
| Spironolactone | 25 | $436 |
| Fluconazole | 44 | $263 |
| Testosterone Cypionate | 21 | $253 |
| Levothyroxine Sodium | 14 | $117 |
| Ibuprofen | 17 | $51 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $350 | $6,17114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 763 obstetrics & gynecology providers in Tennessee.
Other obstetrics & gynecology in Chattanooga
- Daniel HarnsbergerChattanooga$2.5M
- David BarkerChattanooga$446K
- Rayan ElkattahChattanooga$26K
- Kent ChildsChattanooga$23K
- Linda YuChattanooga$19K
- Gary BrunvollChattanooga$11K
- Shevonda SherrowChattanooga$9K
- Benjamin ChappellMemphis$1.2M
- Grover MayJohnson City$916K
- John GreenElizabethton$878K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.